Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00154219 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis
A Phase 3 study of Osteoarthritis, Hip, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,200
- Enrollment target
- 5
- Study locations
NCT00154219: Completed Phase 3 study of Osteoarthritis, Hip, sponsored by Novartis.
NCT00154219 is a Phase 3 study of Osteoarthritis, Hip that has completed, run by Novartis. The registered enrollment target is 1,200 participants, roughly in line with the 1,213-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target. The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00154219, a Phase 3 study of Osteoarthritis, Hip, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to evaluate the efficacy, tolerability, and safety of the investigational drug, lumiracoxib as compared to celecoxib and placebo in subjects with hip osteoarthritis. Both lumiracoxib and celecoxib belong to the same class of drug (COX-2 selective nonsteroidal anti-inflammatory drugs \[NSAIDs\]).
Conditions Studied
Interventions
- DRUG Lumiracoxib (drug)
Study Locations (5)
Other
- Various Sites - Multiple Cities
- Various Sites - Multiple Cities
- Various Sites - Multiple Cities
- Various Sites - Multiple Cities
New Jersey
- For US Site Information, contact Novartis Pharmaceuticals - East Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2004-11 |
| Phase | Phase 3 |
What the finished NCT00154219 record still lists
NCT00154219 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,213-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target.
The record links to 1 condition, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which Lumiracoxib (drug) is the first listed.
NCT00154219 lists 5 locations in 2 states (Other, New Jersey).
Frequently Asked Questions
What is clinical trial NCT00154219 about?
NCT00154219 is a clinical study titled "Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis". The purpose of this study is to evaluate the efficacy, tolerability, and safety of the investigational drug, lumiracoxib as compared to celecoxib and placebo in subjects with hip osteoarthritis. Both lumiracoxib and celecoxib belong to the same class of drug (COX-2 selective nonsteroidal anti-inflam...
What is the current status of trial NCT00154219?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,200 participants. The study started on 2004-11.
What conditions does trial NCT00154219 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip.
What interventions are being tested in trial NCT00154219?
The interventions under investigation include: Lumiracoxib (drug) (DRUG).
Who is sponsoring clinical trial NCT00154219?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00154219 being conducted?
This trial has 5 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00154219's enrollment target sits among peer trials
1,200 5th of 20 higher than 16 of 20 other Osteoarthritis, Hip trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Hip trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
COMPLETED · Phase 3
-
Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
COMPLETED · Phase 3
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee
RECRUITING
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia